173 related articles for article (PubMed ID: 38528047)
21. Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension.
Wang J; Uddin MN; Wang R; Gong YH; Wu Y
Front Genet; 2022; 13():922213. PubMed ID: 36147486
[No Abstract] [Full Text] [Related]
22. Bioinformatics Analysis of Common Genetic and Molecular Traits and Association of Portal Hypertension with Pulmonary Hypertension.
Chen M; Chen Y
J Healthc Eng; 2022; 2022():9237701. PubMed ID: 36312597
[TBL] [Abstract][Full Text] [Related]
23. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G
Can Respir J; 2022; 2022():1394088. PubMed ID: 36072642
[TBL] [Abstract][Full Text] [Related]
24. Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension.
Jiang CY; Wu LW; Liu YW; Feng B; Ye LC; Huang X; He YY; Shen Y; Zhu YF; Zhou XL; Jiang DJ; Qi HK; Zhang H; Yan Y
Front Immunol; 2023; 14():1153573. PubMed ID: 37449198
[TBL] [Abstract][Full Text] [Related]
25. Candidate Genes Identified in Systemic Sclerosis-Related Pulmonary Arterial Hypertension Were Associated with Immunity, Inflammation, and Cytokines.
Xu Z; Ruan J; Pan L; Chen C
Cardiovasc Ther; 2021; 2021():6651009. PubMed ID: 33680092
[TBL] [Abstract][Full Text] [Related]
26. Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Tu J; Jin J; Chen X; Sun L; Cai Z
Front Immunol; 2022; 13():868983. PubMed ID: 35663995
[TBL] [Abstract][Full Text] [Related]
27. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
Zheng Q; Wang D; Lin R; Lv Q; Wang W
Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
[TBL] [Abstract][Full Text] [Related]
28. Identification of biomarkers related to copper metabolism in patients with pulmonary arterial hypertension.
Wang L; Zhang W; Li C; Chen X; Huang J
BMC Pulm Med; 2023 Jan; 23(1):31. PubMed ID: 36690956
[TBL] [Abstract][Full Text] [Related]
29. Weighted gene co-expression network analysis identifies dysregulated B-cell receptor signaling pathway and novel genes in pulmonary arterial hypertension.
Chen Y; Wu C; Wang X; Zhou X; Kang K; Cao Z; Yang Y; Zhong Y; Xiao G
Front Cardiovasc Med; 2022; 9():909399. PubMed ID: 36277750
[TBL] [Abstract][Full Text] [Related]
30. Novel insights into the molecular mechanisms underlying the beneficial effects of exercise training on pulmonary arterial hypertension.
Su Y; Wang J; Quan M
J Sports Med Phys Fitness; 2019 Sep; 59(9):1584-1592. PubMed ID: 30421875
[TBL] [Abstract][Full Text] [Related]
31. Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension.
Dong H; Li X; Cai M; Zhang C; Mao W; Wang Y; Xu Q; Chen M; Wang L; Huang X
Aging (Albany NY); 2021 May; 13(10):14234-14257. PubMed ID: 34016786
[TBL] [Abstract][Full Text] [Related]
32. Identification of immune-associated signatures and potential therapeutic targets for pulmonary arterial hypertension.
He X; Fang J; Gong M; Zhang J; Xie R; Zhao D; Gu Y; Ma L; Pang X; Cui Y
J Cell Mol Med; 2023 Dec; 27(23):3864-3877. PubMed ID: 37753829
[TBL] [Abstract][Full Text] [Related]
33. Identification of Differentially Expressed Genes Associated with Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Approaches.
Zhao E; Xie H; Zhang Y
J Comput Biol; 2021 Jan; 28(1):79-88. PubMed ID: 32493063
[TBL] [Abstract][Full Text] [Related]
34. Identification of MACC1 as a potential biomarker for pulmonary arterial hypertension based on bioinformatics and machine learning.
Zhou X; Liang B; Lin W; Zha L
Comput Biol Med; 2024 May; 173():108372. PubMed ID: 38552277
[TBL] [Abstract][Full Text] [Related]
35. Identification of hub-methylated differentially expressed genes in patients with gestational diabetes mellitus by multi-omic WGCNA basing epigenome-wide and transcriptome-wide profiling.
Chen M; Yan J; Han Q; Luo J; Zhang Q
J Cell Biochem; 2020 Jun; 121(5-6):3173-3184. PubMed ID: 31886571
[TBL] [Abstract][Full Text] [Related]
36. Identification of Biomarkers for Schistosoma-Associated Pulmonary Arterial Hypertension Based on RNA-Seq Data of Mouse Whole Lung Tissues.
Sun Y; Lin X; Li L
Lung; 2017 Jun; 195(3):377-385. PubMed ID: 28393260
[TBL] [Abstract][Full Text] [Related]
37. Identification of autophagy-related biomarkers in patients with pulmonary arterial hypertension based on bioinformatics analysis.
Yang Z; Zhou L; Ge H; Shen W; Shan L
Open Med (Wars); 2022; 17(1):1148-1157. PubMed ID: 35859795
[TBL] [Abstract][Full Text] [Related]
38. Identifying hub genes of calcific aortic valve disease and revealing the immune infiltration landscape based on multiple WGCNA and single-cell sequence analysis.
Wang K; Zheng Q; Liu X; Geng B; Dong N; Shi J
Front Immunol; 2022; 13():1035285. PubMed ID: 36405745
[TBL] [Abstract][Full Text] [Related]
39. Identification of key monocytes/macrophages related gene set of the early-stage abdominal aortic aneurysm by integrated bioinformatics analysis and experimental validation.
Cheng S; Liu Y; Jing Y; Jiang B; Wang D; Chu X; Jia L; Xin S
Front Cardiovasc Med; 2022; 9():950961. PubMed ID: 36186997
[TBL] [Abstract][Full Text] [Related]
40. Identification of ferroptosis-associated genes exhibiting altered expression in pulmonary arterial hypertension.
Zhang F; Liu H
Math Biosci Eng; 2021 Sep; 18(6):7619-7630. PubMed ID: 34814266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
